Alston & Bird represented AOTI Inc, the global leader in multimodality topical wound oxygen therapy, in its initial public offering on the London Stock Exchange’s AIM. AOTI’s admission to AIM is the largest AIM IPO by raise since December 2021. With a market capitalization on admission of £140m, it is the largest AIM IPO since February 2022.
Representing AOTI was an Alston & Bird team led by partners Russell Hilton, Stuart Harray, Dave A. Brown, Rob Ardern, and Mike Stevens, and senior associate Kristina Daniels (Corporate & Business Transactions).